Where the neck has been dissected on a PATIENT with head and neck cancer during a Cancer Care Spell, the size of the largest metastasis, where the UCUM UNIT OF MEASUREMENT is 'Millimetres'.Where the neck has been dissected on a PATIENT with head and neck cancer during a Cancer Care Spell, the size of the largest metastasis, where the UNIT OF MEASUREMENT is 'Millimetres (mm)'.

The maximum depth of invasion of the Tumour, where the UCUM UNIT OF MEASUREMENT is 'Millimetres' .The maximum depth of invasion of the Tumour, where the UNIT OF MEASUREMENT is 'Millimetres (mm)' .

The total volume of milk given to a baby, where the UCUM UNIT OF MEASUREMENT is 'Millilitres (ml)'.The total volume of milk given to a baby, where the UNIT OF MEASUREMENT is 'Millilitres (ml)'.

ALPHA FETOPROTEIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for alpha fetoprotein (AFP) (a protein found in abnormal amounts in the blood of PATIENTS with cancer), where the UCUM UNIT OF MEASUREMENT is 'Nanograms per millilitre (ng/ml)'.ALPHA FETOPROTEIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for alpha fetoprotein (AFP) (a protein found in abnormal amounts in the blood of PATIENTS with cancer), where the UNIT OF MEASUREMENT is 'Nanograms per millilitre (ng/ml)'.

BASE DEFICIT CONCENTRATION (WORST WITHIN 12 HOURS AFTER BIRTH) is the worst deficit result of any Clinical Investigation which measures the PERSON's base excess concentration, where the UCUM UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)', taken within twelve hours of the PERSON BIRTH DATE (BABY).BASE DEFICIT CONCENTRATION (WORST WITHIN 12 HOURS AFTER BIRTH) is the worst deficit result of any Clinical Investigation which measures the PERSON's base excess concentration, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)', taken within twelve hours of the PERSON BIRTH DATE (BABY).

BASE EXCESS CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's base excess concentration, where the UCUM UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'.BASE EXCESS CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's base excess concentration, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'. 

BETA HUMAN CHORIONIC GONADOTROPIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for beta human chorionic gonadotropin (bHCG) (a hormone normally found in the blood and urine during pregnancy), where the UCUM UNIT OF MEASUREMENT is 'International Units per Litre (IU/L)'.BETA HUMAN CHORIONIC GONADOTROPIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for beta human chorionic gonadotropin (bHCG) (a hormone normally found in the blood and urine during pregnancy), where the UNIT OF MEASUREMENT is 'International Units per Litre (IU/L)'.

BETA HUMAN CHORIONIC GONADOTROPIN may also be produced by some Tumour CELLS. An increased level of beta-human chorionic gonadotropin may be a sign of cancer of the testis, uterus, ovary, liver, stomach, pancreas, or lungs.

BIRTH HEAD CIRCUMFERENCE IN CENTIMETRES is result of the Clinical Investigation which measures the Birth Head Circumference, where the UCUM UNIT OF MEASUREMENT is 'Centimetres (cm)'.BIRTH HEAD CIRCUMFERENCE IN CENTIMETRES is result of the Clinical Investigation which measures the Birth Head Circumference, where the UNIT OF MEASUREMENT is 'Centimetres (cm)'.

BIRTH LENGTH IN CENTIMETRES is the result of the Clinical Investigation which measures the Birth Length, where the UCUM UNIT OF MEASUREMENT is 'Centimetres (cm)'.BIRTH LENGTH IN CENTIMETRES is the result of the Clinical Investigation which measures the Birth Length, where the UNIT OF MEASUREMENT is 'Centimetres (cm)'.

BIRTH WEIGHT is the result of the Clinical Investigation which measures the Birth Weight, where the UCUM UNIT OF MEASUREMENT is 'Grams (g)'.BIRTH WEIGHT is the result of the Clinical Investigation which measures the Birth Weight, where the UNIT OF MEASUREMENT is 'Grams (g)'.

The range is 1 to 9998.

BIRTH WEIGHT will be replaced with BIRTH WEIGHT IN GRAMS, which is the most recent approved national information standards to describe the required definition.

BLOOD GLUCOSE CONCENTRATION (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the baby's Blood Glucose Concentration, where the UCUM UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)', on admission to Neonatal Critical Care.BLOOD GLUCOSE CONCENTRATION (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the baby's Blood Glucose Concentration, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)', on admission to Neonatal Critical Care.

The value is presented in the range 0.0 - 50.0.

BLOOD GLUCOSE CONCENTRATION (ON NEONATAL CRITICAL CARE DAILY CARE DATE) is the result of the Clinical Investigation which measures the baby's lowest Blood Glucose Concentration on the Neonatal Critical Care Daily Care Date, where the UCUM UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'.BLOOD GLUCOSE CONCENTRATION (ON NEONATAL CRITICAL CARE DAILY CARE DATE) is the result of the Clinical Investigation which measures the baby's lowest Blood Glucose Concentration on the Neonatal Critical Care Daily Care Date, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'.

The value is presented in the range 0.0 - 50.0.

BRESLOW THICKNESS is the result of the Clinical Investigation which measures the PERSON's Breslow Thickness, where the UCUM UNIT OF MEASUREMENT is 'Millimetres (mm)', to the nearest 0.BRESLOW THICKNESS is the result of the Clinical Investigation which measures the PERSON's Breslow Thickness, where the UNIT OF MEASUREMENT is 'Millimetres (mm)', to the nearest 0.01mm during a Skin Cancer Care Spell.

CD4 CELL COUNT is the result of the Clinical Investigation which measures the PATIENT's CD4 cell count (an indicator of the progress of an Human Immunodeficiency Virus (HIV) infection), where the UCUM UNIT OF MEASUREMENT is 'cells per cubic millimetre (mm³)'.CD4 CELL COUNT is the result of the Clinical Investigation which measures the PATIENT's CD4 cell count (an indicator of the progress of an Human Immunodeficiency Virus (HIV) infection), where the UNIT OF MEASUREMENT is 'Cells per cubic millimetre (mm³)'.

Note: if there is doubt about the sites of the muscularis propria, the distance should be estimated as accurately as possible.

ESTIMATED GLOMERULAR FILTRATION RATE is the result of the Clinical Investigation to determine the PATIENT's Estimated Glomerular Filtration Rate (eGFR), a test that is used to assess how well the kidneys are working.

ESTIMATED GLOMERULAR FILTRATION RATE is a measurement of how many millilitres (ml) of waste fluid the kidneys can filter from the blood in a minute, where the UCUM UNIT OF MEASUREMENT is 'Millilitres per Minute divided by 1.ESTIMATED GLOMERULAR FILTRATION RATE is a measurement of how many millilitres (ml) of waste fluid the kidneys can filter from the blood in a minute, where the UNIT OF MEASUREMENT is 'Millilitres per Minute divided by 1.73 Square Metres (ml/min/1.73m2)'.

For the Cancer Outcomes and Services Data Set - Urological: Urological, ESTIMATED GLOMERULAR FILTRATION RATE is collected once at PATIENT DIAGNOSIS.

FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT) is the result of the Clinical Investigation which measures the PATIENT's Forced Expiratory Volume in 1 second (Absolute Amount), where the UCUM UNIT OF MEASUREMENT is 'Litres (l)'.FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT) is the result of the Clinical Investigation which measures the PATIENT's Forced Expiratory Volume in 1 second (Absolute Amount), where the UNIT OF MEASUREMENT is 'Litres (l)'.

For the Cancer Outcomes and Services Data Set, FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT) is presented in the range 0.10 to 9.99.

FRACTION OF INSPIRED OXYGEN PERCENTAGE is the result of the Clinical Investigation which measures the PERSON's fraction of inspired oxygen (FiO₂), where the UCUM UNIT OF MEASUREMENT is Percentage.FRACTION OF INSPIRED OXYGEN PERCENTAGE is the result of the Clinical Investigation which measures the PERSON's fraction of inspired oxygen (FiO₂), where the UNIT OF MEASUREMENT is 'Percentage (%)'.

For the National Neonatal Data Set - Episodic and Daily Care, FRACTION OF INSPIRED OXYGEN PERCENTAGE indicates the maximum fraction of inspired oxygen percentage that the baby received on the Neonatal Critical Care Daily Care Date.

HEAD CIRCUMFERENCE IN CENTIMETRES is the result of the Clinical Investigation which measures the Head Circumference of a PERSON, where the UCUM UNIT OF MEASUREMENT is 'Centimetres'.HEAD CIRCUMFERENCE IN CENTIMETRES is the result of the Clinical Investigation which measures the Head Circumference of a PERSON, where the UNIT OF MEASUREMENT is 'Centimetres'.

For the National Neonatal Data Set - Episodic and Daily Care, HEAD CIRCUMFERENCE IN CENTIMETRES measures the Head Circumference of a baby on the Neonatal Critical Care Daily Care Date.

LESION SIZE (PATHOLOGICAL) is the diameter of the Lesion, (or largest Lesion if there is more than one), where the histology of a SAMPLE proves to be invasive, where the UCUM UNIT OF MEASUREMENT is 'Millimetres (mm)'.LESION SIZE (PATHOLOGICAL) is the diameter of the Lesion, (or largest Lesion if there is more than one), where the histology of a SAMPLE proves to be invasive, where the UNIT OF MEASUREMENT is 'Millimetres (mm)'.

LESION SIZE (RADIOLOGICAL) is the radiologically estimated size of the maximum diameter of the primary Lesion (or largest Lesion if there is more than one), where the UCUM UNIT OF MEASUREMENT is 'Millimetres (mm)'.LESION SIZE (RADIOLOGICAL) is the radiologically estimated size of the maximum diameter of the primary Lesion (or largest Lesion if there is more than one), where the UNIT OF MEASUREMENT is 'Millimetres (mm)'.

For the Cancer Outcomes and Services Data Set: Central Nervous System, record '00' to indicate the Tumour or Lesion is not assessable for diffuse Tumours (e.g. gliomatosis cerebri).

MAXIMUM BILIRUBIN LEVEL is the result of the Clinical Investigation to determine the PATIENT's maximum bilirubin level (a yellowish substance in the blood that forms after red blood CELLS break down), where the UCUM UNIT OF MEASUREMENT is 'Micromoles per litre ( μmol/l).MAXIMUM BILIRUBIN LEVEL is the result of the Clinical Investigation to determine the PATIENT's maximum bilirubin level (a yellowish substance in the blood that forms after red blood CELLS break down), where the UNIT OF MEASUREMENT is 'Micromoles per litre ( μmol/l).

For the National Neonatal Data Set - Episodic and Daily Care, MAXIMUM BILIRUBIN LEVEL is the maximum bilirubin level on the Neonatal Critical Care Daily Care Date.

MEAN ARTERIAL BLOOD PRESSURE (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the mean Arterial Blood Pressure of the baby, calculated using the Systolic Blood Pressure and Diastolic Blood Pressure, where the UCUM UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)', on admission to Neonatal Critical Care.MEAN ARTERIAL BLOOD PRESSURE (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the mean Arterial Blood Pressure of the baby, calculated using the Systolic Blood Pressure and Diastolic Blood Pressure, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)', on admission to Neonatal Critical Care.

The value is in the range of 10-150.

MITOTIC RATE (SARCOMA) is the result of the Clinical Investigation which measures the PATIENT's Mitotic Rate (MR) (a measure of how fast cancer CELLS are dividing and growing), where the UCUM UNIT OF MEASUREMENT is '5 Millimetres Squared', during a Sarcoma Cancer Care Spell.MITOTIC RATE (SARCOMA) is the result of the Clinical Investigation which measures the PATIENT's Mitotic Rate (MR) (a measure of how fast cancer CELLS are dividing and growing), where the UNIT OF MEASUREMENT is '5 Millimetres Squared', during a Sarcoma Cancer Care Spell.

MITOTIC RATE (SKIN) is the outcome of the Clinical Investigation which measures the PATIENT's Mitotic Rate (MR) (a measure of how fast cancer CELLS are dividing and growing), where the UCUM UNIT OF MEASUREMENT is 'Square Millimetre (mm²)', during a Skin Cancer Care Spell.MITOTIC RATE (SKIN) is the outcome of the Clinical Investigation which measures the PATIENT's Mitotic Rate (MR) (a measure of how fast cancer CELLS are dividing and growing), where the UNIT OF MEASUREMENT is 'Square Millimetre (mm²)', during a Skin Cancer Care Spell.

NON INVASIVE TUMOUR SIZE is the size of the non invasive Tumour.

For the Cancer Outcomes and Services Data Set, NON INVASIVE TUMOUR SIZE is only required if there is no invasive component.

PARTIAL PRESSURE CARBON DIOXIDE is the result of the Clinical Investigation which measures the PERSON's partial pressure carbon dioxide (PCO₂) level, where the UCUM UNIT OF MEASUREMENT is 'Kilopascals (KPa)'.PARTIAL PRESSURE CARBON DIOXIDE is the result of the Clinical Investigation which measures the PERSON's partial pressure carbon dioxide (PCO₂) level, where the UNIT OF MEASUREMENT is 'Kilopascals (KPa)'.

PERSON HEIGHT IN CENTIMETRES is the result of the Clinical Investigation which measures the PATIENT's Height, where the UCUM UNIT OF MEASUREMENT is Centimetres (cm).PERSON HEIGHT IN CENTIMETRES is the result of the Clinical Investigation which measures the PATIENT's Height, where the UNIT OF MEASUREMENT is 'Centimetres (cm)'.

This item is not referenced in a data set in the NHS Data Model and Dictionary. It has been retained for information.

PERSON HEIGHT IN METRES is the result of the Clinical Investigation which measures the PATIENT's Height, where the UCUM UNIT OF MEASUREMENT is 'Metres (m)'.PERSON HEIGHT IN METRES is the result of the Clinical Investigation which measures the PATIENT's Height, where the UNIT OF MEASUREMENT is 'Metres (m)'.

For the Systemic Anti-Cancer Therapy Data Set, PERSON HEIGHT IN METRES is the Height at the start of the Systemic Anti-Cancer Therapy Drug Regimen.

PERSON HEIGHT IN METRES (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN) is the result of the Clinical Investigation which measures the Height of the PATIENT at the start of the Systemic Anti-Cancer Therapy Drug Regimen, where the UCUM UNIT OF MEASUREMENT is 'Metres (m)'.PERSON HEIGHT IN METRES (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN) is the result of the Clinical Investigation which measures the Height of the PATIENT at the start of the Systemic Anti-Cancer Therapy Drug Regimen, where the UNIT OF MEASUREMENT is 'Metres (m)'.

PERSON LENGTH IN CENTIMETRES is the result of the Clinical Investigation which measures the Length of a baby, where the UCUM UNIT OF MEASUREMENT is 'Centimetres'.PERSON LENGTH IN CENTIMETRES is the result of the Clinical Investigation which measures the Length of a baby, where the UNIT OF MEASUREMENT is 'Centimetres (cm)'.

For the National Neonatal Data Set - Episodic and Daily Care, PERSON LENGTH IN CENTIMETRES measures the Length of a baby on the Neonatal Critical Care Daily Care Date.

PERSON WEIGHT is the result of the Clinical Investigation which measures the PATIENT's Weight, where the UCUM UNIT OF MEASUREMENT is 'Kilograms (kg)'.PERSON WEIGHT is the result of the Clinical Investigation which measures the PATIENT's Weight, where the UNIT OF MEASUREMENT is 'Kilograms (kg)'.

Notes:

• For Neonatal Critical Care Minimum Data Set, PERSON WEIGHT will be the last recorded Weight on a particular ACTIVITY DATE (CRITICAL CARE)
• For the Systemic Anti-Cancer Therapy Data Set, PERSON WEIGHT is the Weight at the start of the:
  • Systemic Anti-Cancer Therapy Drug Regimen and
  • Systemic Anti-Cancer Therapy Drug Cycle.

PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE) is the result of the Clinical Investigation which measures the PATIENT's Weight at the start of the Systemic Anti-Cancer Therapy Drug Cycle, where the UCUM UNIT OF MEASUREMENT is 'Kilograms (kg)'.PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE) is the result of the Clinical Investigation which measures the PATIENT's Weight at the start of the Systemic Anti-Cancer Therapy Drug Cycle, where the UNIT OF MEASUREMENT is 'Kilograms (kg)'.

PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN) is the result of the Clinical Investigation which measures the PATIENT's Weight at the start of the Systemic Anti-Cancer Therapy Drug Regimen, where the UCUM UNIT OF MEASUREMENT is 'Kilograms (kg)'.PERSON WEIGHT (START OF SYSTEMIC ANTI-CANCER THERAPY DRUG REGIMEN) is the result of the Clinical Investigation which measures the PATIENT's Weight at the start of the Systemic Anti-Cancer Therapy Drug Regimen, where the UNIT OF MEASUREMENT is 'Kilograms (kg)'.

PERSON WEIGHT IN GRAMS is the result of the Clinical Investigation which measures the Weight of a PERSON, where the UCUM UNIT OF MEASUREMENT is 'Grams'.PERSON WEIGHT IN GRAMS is the result of the Clinical Investigation which measures the Weight of a PERSON, where the UNIT OF MEASUREMENT is 'Grams (g)'.

The value is presented in the range 1 - 9998.

For the National Neonatal Data Set - Episodic and Daily Care, PERSON WEIGHT IN GRAMS is the Weight of a baby on the Neonatal Critical Care Daily Care Date.

PROSTATE SPECIFIC ANTIGEN (DIAGNOSIS) is the result of the Clinical Investigation to measure the Prostate Specific Antigen (a protein made by the prostate gland and found in the blood) at the time of PATIENT DIAGNOSIS for prostate cancer, where the UCUM UNIT OF MEASUREMENT is 'Nanograms per millilitre (ng/ml)'.PROSTATE SPECIFIC ANTIGEN (DIAGNOSIS) is the result of the Clinical Investigation to measure the Prostate Specific Antigen (a protein made by the prostate gland and found in the blood) at the time of PATIENT DIAGNOSIS for prostate cancer, where the UNIT OF MEASUREMENT is 'Nanograms per millilitre (ng/ml)'.

Notes:
SYSTOLIC BLOOD PRESSURE is the same as attribute CLINICAL INVESTIGATION RESULT VALUE.

SYSTOLIC BLOOD PRESSURE is the result of the Clinical Investigation which measures the PATIENT's Systolic Blood Pressure, where the UCUM UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'.SYSTOLIC BLOOD PRESSURE is the result of the Clinical Investigation which measures the PATIENT's Systolic Blood Pressure, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'.

This item is not referenced in a data set in the NHS Data Model and Dictionary. It has been retained for information.

TEMPERATURE (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the Temperature of the baby, where the UCUM UNIT OF MEASUREMENT is 'Celsius (ºC)', taken within 60 minutes of admission to Neonatal Critical CareTEMPERATURE (ON ADMISSION TO NEONATAL CRITICAL CARE) is the result of the Clinical Investigation which measures the Temperature of the baby, where the UNIT OF MEASUREMENT is 'Celsius (ºC)', taken within 60 minutes of admission to Neonatal Critical Care

TUMOUR HEIGHT ABOVE ANAL VERGE is the approximate height of the lower limit of the Tumour above the anal verge (as measured by a rigid sigmoidoscopy), where the UCUM UNIT OF MEASUREMENT is 'Centimetres (cm)' during a Colorectal Cancer Care Spell.TUMOUR HEIGHT ABOVE ANAL VERGE is the approximate height of the lower limit of the Tumour above the anal verge (as measured by a rigid sigmoidoscopy), where the UNIT OF MEASUREMENT is 'Centimetres (cm)' during a Colorectal Cancer Care Spell.

UMBILICAL CORD BLOOD LACTATE LEVEL is the result of the Clinical Investigation which measures the lactate level of blood taken from the umbilical cord after Delivery of the baby, where the UCUM UNIT OF MEASUREMENT is Millimoles per Litre (mmol/l).UMBILICAL CORD BLOOD LACTATE LEVEL is the result of the Clinical Investigation which measures the lactate level of blood taken from the umbilical cord after Delivery of the baby, where the UNIT OF MEASUREMENT is Millimoles per Litre (mmol/l).

VIRAL LOAD COUNT is the result of the Clinical Investigation which measures the PATIENT's viral load count, where the UCUM UNIT OF MEASUREMENT is 'copies per millilitre (mL)'.VIRAL LOAD COUNT is the result of the Clinical Investigation which measures the PATIENT's viral load count, where the UNIT OF MEASUREMENT is 'Copies per millilitre (copies/mL)'.

WHITE BLOOD CELL COUNT is the result of the Clinical Investigation which measures the PERSON's white CELL blood count, where the UCUM UNIT OF MEASUREMENT is 'number times ten raised to the power of nine per litre (x10⁹/l)'.WHITE BLOOD CELL COUNT is the result of the Clinical Investigation which measures the PERSON's white CELL blood count, where the UNIT OF MEASUREMENT is 'Number times ten raised to the power of nine per litre (x10⁹/l)'.

WHOLE TUMOUR SIZE is the whole size of the Tumour and is only required where the Tumour has a DUCTAL CARCINOMA IN SITU GRADE.